1. Home
  2. HWKN vs RCUS Comparison

HWKN vs RCUS Comparison

Compare HWKN & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hawkins Inc.

HWKN

Hawkins Inc.

HOLD

Current Price

$134.95

Market Cap

2.7B

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$25.20

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HWKN
RCUS
Founded
1938
2015
Country
United States
United States
Employees
N/A
674
Industry
Specialty Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
3.1B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
HWKN
RCUS
Price
$134.95
$25.20
Analyst Decision
Buy
Buy
Analyst Count
2
8
Target Price
$200.00
$28.75
AVG Volume (30 Days)
147.6K
1.7M
Earning Date
10-29-2025
10-28-2025
Dividend Yield
0.56%
N/A
EPS Growth
1.59
N/A
EPS
3.97
N/A
Revenue
$1,045,229,000.00
$240,000,000.00
Revenue This Year
$15.55
N/A
Revenue Next Year
$6.48
N/A
P/E Ratio
$34.13
N/A
Revenue Growth
11.86
N/A
52 Week Low
$98.30
$6.50
52 Week High
$186.15
$26.35

Technical Indicators

Market Signals
Indicator
HWKN
RCUS
Relative Strength Index (RSI) 47.44 76.68
Support Level $127.65 $19.44
Resistance Level $132.48 $26.32
Average True Range (ATR) 5.50 1.28
MACD 2.35 0.38
Stochastic Oscillator 93.13 84.34

Price Performance

Historical Comparison
HWKN
RCUS

About HWKN Hawkins Inc.

Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers. The majority of revenue is gained from Water Treatment.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: